← Back to catalogue
Disposable Core Biopsy Instruments
EUDAMEDClass IIa (EU MDR)
Ref 100022112Model BN-OCR-1/1410A,BN-OCR-1/1410B,BN-OCR-1/1410C,BN-OCR-1/1416A,BN-OCR-1/1416B,BN-OCR-1/1416C,BN-OCR-1/1610A,BN-OCR-1/1610B,BN-OCR-1/1610C,BN-OCR-1/1616A,BN-OCR-1/1616B,etc
Identity
- Trade Name
- Disposable Core Biopsy Instruments EUDAMED
- Device Name
- Disposable Core Biopsy Instruments EUDAMED
- Model / Reference
- BN-OCR-1/1410A,BN-OCR-1/1410B,BN-OCR-1/1410C,BN-OCR-1/1416A,BN-OCR-1/1416B,BN-OCR-1/1416C,BN-OCR-1/1610A,BN-OCR-1/1610B,BN-OCR-1/1610C,BN-OCR-1/1616A,BN-OCR-1/1616B,etc EUDAMED100022112 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 06942067975843 EUDAMED
- Basic UDI-DI
- 69420679BN-OCR-1SN EUDAMED
- EMDN Code
- A01020199 NEEDLES AND KITS FOR HISTOLOGICAL AND CYTOLOGICAL BIOPSY OF SOFT TISSUES - OTHER EUDAMED
Classification
- Device Class
- Class IIa EUDAMED
- Market of Registration
- France EUDAMED
Clinical & Handling
Sterile
Yes
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Disposable Core Biopsy Instruments by Ningbo Xinwell Medical Technology Co., Ltd. — Class IIa — MDR — listed in EUDAMED — regulatory data on deviCERTS
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | 69420679BN-OCR-1SN | Class IIa | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Ningbo Xinwell Medical Technology Co., Ltd
- EUDAMED SRN
- CN-MF-000001084
- Authorised Representative
- Lotus NL B.V. NL-AR-000000121
Sources (1)
- EUDAMED 8fb564a7-9807-44b7-a52f-e471a24f2eeb 61 fields · synced Jun 18, 2026